Nieraj Jain, MD
Ophthalmology · Portland, ORNPI 1306962774
Payments from drug & device makers
What this record shows
Alcon accounts for 78.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for ophthalmology clinicians in OR, where the typical reported total is $540.
Across 3 payments — averaging $201.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$478
- Carl Zeiss Meditec USA, Inc.$128
Across 34 payments — averaging $6903.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$235K
What the payments were for
- Travel & lodging$34857%
- Food & beverage$25843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 2 | $478 |
| Carl Zeiss Meditec USA, Inc. | 1 | $128 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$348
- Constellation$130
- CLARUS$128
How this compares
$606 in reported general payments places this provider in the 50th percentile of 248 ophthalmology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 39 | $1,120 |
| Prednisolone Acetate | 20 | $631 |
| Latanoprost | 15 | $347 |
| Dorzolamide Hcl | 18 | $328 |
| Timolol Maleate | 28 | $293 |
| Brimonidine Tartrate | 17 | $114 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Portland
- Mark PennesiPortland$56K
- Rene ChoiPortland$21K
- Richard WeleberPortland$14K
- Aazim SiddiquiPortland$13K
- Richard StutzmanPortland$10K
- Matthew KaufmanPortland$8K
- Paul YangPortland$7K
- Monia RedingPortland$5K
- Richard DreyerPortland$5K
- Andrea YongePortland$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.